Ubs Group Ag Aerie Pharmaceuticals Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$6.37 - $15.23 $4.43 Million - $10.6 Million
695,195 Added 40.64%
2,405,832 $36.4 Million
Q2 2022

Aug 10, 2022
BUY
$4.95 - $9.16 $498,865 - $923,153
100,781 Added 6.26%
1,710,637 $12.8 Million
Q1 2022

May 16, 2022
BUY
$5.64 - $9.8 $9.04 Million - $15.7 Million
1,602,984 Added 23326.31%
1,609,856 $14.7 Million
Q4 2021

Feb 14, 2022
BUY
$7.02 - $13.33 $25,587 - $48,587
3,645 Added 112.95%
6,872 $48,000
Q3 2021

Nov 15, 2021
SELL
$11.32 - $16.63 $603,220 - $886,179
-53,288 Reduced 94.29%
3,227 $37,000
Q2 2021

Aug 13, 2021
BUY
$15.16 - $18.97 $752,466 - $941,575
49,635 Added 721.44%
56,515 $905,000
Q1 2021

May 12, 2021
BUY
$13.12 - $20.9 $28,719 - $45,750
2,189 Added 46.66%
6,880 $123,000
Q4 2020

Feb 11, 2021
SELL
$9.12 - $14.49 $65,317 - $103,777
-7,162 Reduced 60.42%
4,691 $63,000
Q3 2020

Nov 12, 2020
BUY
$10.46 - $14.46 $44,842 - $61,990
4,287 Added 56.66%
11,853 $140,000
Q2 2020

Jul 31, 2020
SELL
$12.0 - $16.13 $4.76 Million - $6.39 Million
-396,307 Reduced 98.13%
7,566 $111,000
Q1 2020

May 01, 2020
SELL
$11.84 - $25.52 $860,578 - $1.85 Million
-72,684 Reduced 15.25%
403,873 $5.45 Million
Q4 2019

Feb 14, 2020
BUY
$17.72 - $25.1 $8.43 Million - $11.9 Million
475,557 Added 47555.7%
476,557 $11.5 Million
Q2 2019

Aug 14, 2019
SELL
$28.97 - $48.21 $21,785 - $36,253
-752 Reduced 42.92%
1,000 $30,000
Q1 2019

May 14, 2019
SELL
$36.32 - $49.25 $63,487 - $86,089
-1,748 Reduced 49.94%
1,752 $84,000
Q4 2018

Feb 14, 2019
SELL
$33.0 - $60.04 $153,813 - $279,846
-4,661 Reduced 57.11%
3,500 $126,000
Q3 2018

Nov 14, 2018
SELL
$56.15 - $73.9 $1.62 Million - $2.14 Million
-28,913 Reduced 77.99%
8,161 $502,000
Q2 2018

Aug 14, 2018
BUY
$47.85 - $70.45 $1.32 Million - $1.95 Million
27,665 Added 294.03%
37,074 $2.5 Million
Q1 2018

May 15, 2018
BUY
$51.15 - $61.0 $282,654 - $337,086
5,526 Added 142.31%
9,409 $511,000
Q4 2017

Feb 14, 2018
SELL
$50.85 - $65.1 $1.83 Million - $2.34 Million
-36,005 Reduced 90.27%
3,883 $232,000
Q3 2017

Nov 14, 2017
BUY
$48.6 - $60.1 $1.87 Million - $2.31 Million
38,438 Added 2650.9%
39,888 $1.94 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-1,073 Reduced 42.53%
1,450 $76,000
Q1 2017

Nov 14, 2017
BUY
N/A
2,523
2,523 $114,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email